311 related articles for article (PubMed ID: 29401734)
1. Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules.
Gouveia MJ; Brindley PJ; Gärtner F; Costa JMCD; Vale N
Pharmaceuticals (Basel); 2018 Feb; 11(1):. PubMed ID: 29401734
[TBL] [Abstract][Full Text] [Related]
2. Current and Novel Therapies Against Helminthic Infections: The Potential of Antioxidants Combined with Drugs.
Vale N; Gouveia MJ; Gärtner F
Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32106428
[TBL] [Abstract][Full Text] [Related]
3. Activity of Combinations of Antioxidants and Anthelmintic Drugs against the Adult Stage of
Gouveia MJ; Brindley PJ; Gärtner F; Vale N
J Parasitol Res; 2020; 2020():8843808. PubMed ID: 32832132
[TBL] [Abstract][Full Text] [Related]
4. Combination Anthelmintic/Antioxidant Activity Against
Gouveia MJ; Brindley PJ; Rinaldi G; Gärtner F; Correia da Costa JM; Vale N
Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30764562
[TBL] [Abstract][Full Text] [Related]
5. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
[TBL] [Abstract][Full Text] [Related]
6. Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica.
Xu J; Dong LL; Sun H; Huang P; Zhang RZ; Wang XY; Sun DQ; Xia CM
PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011215. PubMed ID: 37410790
[TBL] [Abstract][Full Text] [Related]
7. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
Doenhoff MJ; Cioli D; Utzinger J
Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
[TBL] [Abstract][Full Text] [Related]
8. Antioxidants resveratrol and SkQ1 attenuate praziquantel adverse effects on the liver in Opisthorchis felineus infected hamsters.
Zaparina O; Rakhmetova AS; Kolosova NG; Cheng G; Mordvinov VA; Pakharukova MY
Acta Trop; 2021 Aug; 220():105954. PubMed ID: 33979641
[TBL] [Abstract][Full Text] [Related]
9. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
Bergquist R; Utzinger J; Keiser J
Infect Dis Poverty; 2017 Mar; 6(1):74. PubMed ID: 28351414
[TBL] [Abstract][Full Text] [Related]
10. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Synriam™, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni.
Mossallam SF; Amer EI; El-Faham MH
Acta Trop; 2015 Mar; 143():36-46. PubMed ID: 25530543
[TBL] [Abstract][Full Text] [Related]
12. Current drug strategies for the treatment and control of schistosomiasis.
Villamizar-Monsalve MA; López-Abán J; Vicente B; Peláez R; Muro A
Expert Opin Pharmacother; 2024 Mar; 25(4):409-420. PubMed ID: 38511392
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
Liu LX; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
[TBL] [Abstract][Full Text] [Related]
14. Antimalarials in the treatment of schistosomiasis.
Keiser J; Utzinger J
Curr Pharm Des; 2012; 18(24):3531-8. PubMed ID: 22607145
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Antischistosomal Drugs and Agents.
Liu L; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2016 Jun; ():. PubMed ID: 27364000
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Antischistosomal Drugs and Agents.
Liang-Xian L; Fan CQ; Xiao-Lin
Mini Rev Med Chem; 2013 Jan; ():. PubMed ID: 23373655
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics reveal alterations in arachidonic acid metabolism in Schistosoma mekongi after exposure to praziquantel.
Chienwichai P; Tipthara P; Tarning J; Limpanont Y; Chusongsang P; Chusongsang Y; Adisakwattana P; Reamtong O
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009706. PubMed ID: 34473691
[TBL] [Abstract][Full Text] [Related]
18. Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel.
Kasinathan RS; Sharma LK; Cunningham C; Webb TR; Greenberg RM
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3265. PubMed ID: 25330312
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the antioxidant defence in different developmental stages of Schistosoma mansoni by praziquantel and artemether.
El-Bassiouni EA; Helmy MH; Saad EI; El-Nabi Kamel MA; Abdel-Meguid E; Hussein HS
Br J Biomed Sci; 2007; 64(4):168-74. PubMed ID: 18236739
[TBL] [Abstract][Full Text] [Related]
20. Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment.
Meyer T; Sekljic H; Fuchs S; Bothe H; Schollmeyer D; Miculka C
PLoS Negl Trop Dis; 2009; 3(1):e357. PubMed ID: 19159015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
